Expertise in
3
conditions

Dr. Daniel G. Lorch

Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
910 Oakfield Dr, Suite 102, 
Brandon, FL 
Expertise in
3
conditions
910 Oakfield Dr, Suite 102, 
Brandon, FL 

Overview

Daniel Lorch is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Brandon, Florida. Dr. Lorch is highly rated in 3 conditions, according to our data. His top areas of expertise are Lung Metastases, Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Bronchiectasis, and Advanced Bronchoscopy.

His clinical research consists of co-authoring 7 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Pulmonary Medicine
Intensive Care Medicine
Sleep Medicine

Licenses

Internal Medicine in FL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

910 Oakfield Dr, Suite 102, Brandon, FL 33511

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Master Protocol to Investigate the Efficacy and Safety of Tirzepatide Once Weekly in Participants Who Have Obstructive Sleep Apnea and Obesity: A Randomized, Double-Blind, Placebo-Controlled Trial
A Master Protocol to Investigate the Efficacy and Safety of Tirzepatide Once Weekly in Participants Who Have Obstructive Sleep Apnea and Obesity: A Randomized, Double-Blind, Placebo-Controlled Trial
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
Enrollment Status: Completed
Publish Date: June 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With Standard of Care Versus Standard of Care in Subjects Hospitalized With COVID-19
A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With Standard of Care Versus Standard of Care in Subjects Hospitalized With COVID-19
Enrollment Status: Completed
Publish Date: January 18, 2023
Intervention Type: Drug, Other
Study Drug: Abivertinib
Study Phase: Phase 2
Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea
Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: December 12, 2022
Intervention Type: Drug
Study Drugs: AD109, AD504, Atomoxetine Hydrochloride
Study Phase: Phase 2
A Randomized, Blinded-controlled Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adult Patients With COVID-19
A Randomized, Blinded-controlled Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adult Patients With COVID-19
Enrollment Status: Withdrawn
Publish Date: August 16, 2022
Intervention Type: Drug, Biological
Study Drug: COVI-AMG COVID-19 Vaccine
Study Phase: Phase 2
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
Enrollment Status: Completed
Publish Date: September 23, 2019
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Enrollment Status: Completed
Publish Date: January 16, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

7 Total Publications

Respiratory safety of lemborexant in adult and elderly subjects with moderate-to-severe chronic obstructive pulmonary disease.
Respiratory safety of lemborexant in adult and elderly subjects with moderate-to-severe chronic obstructive pulmonary disease.
Journal: Journal of sleep research
Published: May 02, 2024
Similar Doctors
Expertise in
14
conditions
Dr. Debabrata S. Bandyopadhyay
Intensive Care Medicine | Pulmonary Medicine
Expertise in
14
conditions
Dr. Debabrata S. Bandyopadhyay
Intensive Care Medicine | Pulmonary Medicine
13330 Usf Laurel Dr, 
Tampa, FL 
 (11.8 miles away)
813-974-2201
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Debabrata Bandyopadhyay is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Tampa, Florida. Dr. Bandyopadhyay is highly rated in 14 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Sarcoidosis, Bone Graft, and Lung Transplant. Dr. Bandyopadhyay is currently accepting new patients.

Expertise in
22
conditions
Dr. Christina E. Rigas
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Expertise in
22
conditions
Dr. Christina E. Rigas
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
10707 66th St N, Suite B, 
Pinellas Park, FL 
 (26.7 miles away)
727-234-5580
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christina Rigas is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Pinellas Park, Florida. Dr. Rigas is highly rated in 22 conditions, according to our data. Her top areas of expertise are Lung Metastases, Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), and Bronchiectasis. Dr. Rigas is currently accepting new patients.

Expertise in
11
conditions
Dr. Arthur E. Graves
Pulmonary Medicine | Intensive Care Medicine
Expertise in
11
conditions
Dr. Arthur E. Graves
Pulmonary Medicine | Intensive Care Medicine
910 Oakfield Dr, Suite 102, 
Brandon, FL 
 (0.1 miles away)
813-681-4413
Languages Spoken:
English
See accepted insurances

Arthur Graves is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Brandon, Florida. Dr. Graves is highly rated in 11 conditions, according to our data. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Atypical Pneumonia, Hospital-Acquired Pneumonia, and Advanced Bronchoscopy.

Frequently Asked Questions about Dr. Daniel G. Lorch

How do I make an appointment with Dr. Daniel G. Lorch?

You can book an appointment with Dr. Daniel G. Lorch by calling their office at 813-681-4413. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Daniel G. Lorch a top-rated expert for Lung Metastases?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Daniel G. Lorch is classified as an Advanced expert for Lung Metastases, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Daniel G. Lorch specialize in?

While Dr. Daniel G. Lorch is a Pulmonary Medicine, they have specific expertise in Lung Metastases, Obstructive Sleep Apnea, and Chronic Obstructive Pulmonary Disease (COPD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Daniel G. Lorch participate in research or clinical trials?

Yes. Dr. Daniel G. Lorch has published 7 articles and abstracts on conditions like Lung Metastases. You can view a list of Dr. Daniel G. Lorch's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Daniel G. Lorch accept my insurance?

Dr. Daniel G. Lorch accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 813-681-4413 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lorch's expertise for a condition
ConditionClose
      View All 37 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile